TELA Bio (TELA) FCF Margin Growth (3y) (2021 - 2026)
TELA Bio (TELA) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -472.00 |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -20.00 |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | 3,892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,892.00 |
| Dec 31, 2025 | 6,368.00 |
| Sep 30, 2025 | 4,598.00 |
| Jun 30, 2025 | 7,077.00 |
| Mar 31, 2025 | 7,811.00 |
| Dec 31, 2024 | 6,804.00 |
| Sep 30, 2024 | 3,926.00 |
| Jun 30, 2024 | 908.00 |
| Mar 31, 2024 | 5,876.00 |
| Dec 31, 2023 | 5,981.00 |
| Sep 30, 2023 | 2,141.00 |
| Jun 30, 2023 | 10,475.00 |
| Mar 31, 2023 | 9,978.00 |
| Dec 31, 2022 | 6,092.00 |
| Sep 30, 2022 | 6,208.00 |
| Jun 30, 2022 | 4,835.00 |
| Mar 31, 2022 | 10,589.00 |
| Dec 31, 2021 | 12,300.00 |